Segment Information (Tables)

3 Months Ended

Sep. 30, 2014

Schedule of segment performance measures

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2014
Net sales	$	49,079	$	37,977	$	43,747	$	-		$	130,803
Gross profit		14,541		6,150		6,960		-			27,651
Income (loss) before income taxes		5,457		1,533		1,924		(1,269	)		7,645

2013
Net sales	$	38,694	$	48,424	$	42,143	$	-		$	129,261
Gross profit		11,141		15,262		7,331		-			33,734
Income (loss) before income taxes		5,535		11,004		3,302		(2,267	)		17,574

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details